Are Kingfa Science & Technology (India) Ltd latest results good or bad?

1 hour ago
share
Share Via
Kingfa Science & Technology (India) Ltd's latest Q4 FY26 results are strong, with a net profit of ₹59.15 crores and revenue of ₹578.47 crores, reflecting significant growth. However, high valuation metrics may raise caution for potential investors.
Kingfa Science & Technology (India) Ltd's latest financial results for Q4 FY26 reflect a strong operational performance, showcasing significant growth across various metrics. The company reported a net profit of ₹59.15 crores, which marks a notable quarter-on-quarter increase of 30.96% and a year-on-year surge of 41.15%. This growth in profitability is complemented by a revenue of ₹578.47 crores for the quarter, representing an 18.19% increase from the previous quarter and a 23.20% rise compared to the same quarter last year.
The operating margin also showed improvement, reaching 14.0%, which is the highest in multiple quarters, indicating enhanced operational efficiency and a favorable product mix in the industrial plastics segment. The company's return on equity (ROE) stands at 23.06%, reflecting strong capital efficiency and profitability, which is significantly above industry averages. For the full fiscal year FY2025, Kingfa Science achieved a revenue of ₹1,744 crores, marking a 17.3% growth over FY2024. The consistent margin expansion from 12.4% in FY2024 to 12.9% in FY2025, and further to 14.0% in Q4 FY26, underscores the company's ability to enhance its operational leverage as it scales. Despite these positive operational trends, the company has faced valuation concerns, as indicated by its premium price-to-earnings multiple of 44x and price-to-book ratio of 10.22x. This has led to an adjustment in its evaluation, reflecting the market's perception of its growth potential relative to its current pricing. Overall, Kingfa Science & Technology (India) Ltd's recent financial results demonstrate a robust growth trajectory and operational excellence, although valuation metrics suggest a premium pricing that may warrant caution for potential investors.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News